COS have been reported to attenuate inflammation and related inflammatory injury by inhibiting NF-κB-mediated inflammation and apoptosis in LPS-stimulated intestinal epithelial cells (IECs) in vitro and in the colonic tissues of mice with colitis in vivo [20,21]. The gene discussed is NFKB1; the disease is colitis.